Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.

scientific article published on 19 September 2011

Anatabine lowers Alzheimer's Aβ production in vitro and in vivo. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJPHAR.2011.09.019
P698PubMed publication ID21958873
P5875ResearchGate publication ID51681118

P50authorMichael MullanQ41779102
Ghania Ait-GhezalaQ56978157
P2093author name stringFiona Crawford
Jon Reed
Corbin Bachmeier
Daniel Paris
Alex Bishop
David Beaulieu-Abdelahad
Jin Chao
Venkat Mathura
P433issue2-3
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
anatabineQ487291
P304page(s)384-391
P577publication date2011-09-19
P1433published inEuropean Journal of PharmacologyQ1376712
P1476titleAnatabine lowers Alzheimer's Aβ production in vitro and in vivo
P478volume670

Reverse relations

cites work (P2860)
Q89697322A Pharmacological Comparison of Two Isomeric Nicotinic Receptor Agonists: The Marine Toxin Isoanatabine and the Tobacco Alkaloid Anatabine
Q38790372Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain Injury
Q28485371Amelioration of experimental autoimmune encephalomyelitis by anatabine
Q98778777Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis
Q37592815Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trial
Q45342642Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-κB and NLRP3 inflammasome activation
Q28547449Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
Q37389287Effects of a facial cream containing the minor alkaloid anatabine on improving the appearance of the skin in mild to moderate rosacea: an open-label case series study
Q37302467Effects of dietary supplementation with the solanaceae plant alkaloid anatabine on joint pain and stiffness: results from an internet-based survey study
Q64077852GTS-21 has cell-specific anti-inflammatory effects independent of α7 nicotinic acetylcholine receptors
Q42509129Loss of Smooth Muscle α-Actin Leads to NF-κB-Dependent Increased Sensitivity to Angiotensin II in Smooth Muscle Cells and Aortic Enlargement.
Q72543292Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease
Q27340418Nicotine from edible Solanaceae and risk of Parkinson disease
Q39338754Nuclear factor-κB regulates βAPP and β- and γ-secretases differently at physiological and supraphysiological Aβ concentrations
Q39380158The effects of anatabine on non-invasive indicators of muscle damage: a randomized, double-blind, placebo-controlled, crossover study
Q34444298The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation
Q38062499Transcriptional and post-transcriptional regulation of β-secretase.